Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.00 USD
Change Today +0.02 / 0.40%
Volume 20.9K
SURG On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ CM
As of 11:15 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

synergetics usa inc (SURG) Snapshot

Open
$5.00
Previous Close
$4.98
Day High
$5.00
Day Low
$4.96
52 Week High
04/15/15 - $5.95
52 Week Low
07/18/14 - $2.95
Market Cap
127.8M
Average Volume 10 Days
180.2K
EPS TTM
$0.15
Shares Outstanding
25.6M
EX-Date
--
P/E TM
32.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for SYNERGETICS USA INC (SURG)

Related News

No related news articles were found.

synergetics usa inc (SURG) Related Businessweek News

No Related Businessweek News Found

synergetics usa inc (SURG) Details

Synergetics USA, Inc., a medical device company, provides precision surgical devices, surgical equipment, and consumables primarily for the ophthalmology and neurosurgery markets in the United States and internationally. The company’s product lines focuses upon precision engineered disposable and reusable devices, surgical equipment, procedural kits, and the delivery of various energy modalities, including laser energy, ultrasonic energy, radio frequency energy for electro surgery and lesion generation, and visible light energy for illumination. It offers approximately 1,000 separate catalogue items in the vitreoretinal surgical market, including vitrectomy system under the VersaVIT 2.0 brand; procedural packs under VersaPACK and Core Essentials brands; fiberoptic endoilluminators and endolaser probes; various disposable and reusable devices designed for intraocular manipulation of tissues; illumination equipment under the Photon brand; laser equipment for the United States market under Ellex’s Solitaire brand; Volk’s line of ophthalmic lenses; Labtician’s scleral buckles; and other miscellaneous products. The company sells its products directly, as well as through distributors and independent sales representatives to end-users at hospitals, ambulatory surgery centers, and surgeon offices. Synergetics USA, Inc. is headquartered in O’Fallon, Missouri.

373 Employees
Last Reported Date: 10/14/14

synergetics usa inc (SURG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $421.1K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $286.4K
Vice President of Marketing & Technology
Total Annual Compensation: $269.1K
Vice President of Domestic Sales
Total Annual Compensation: $229.2K
Compensation as of Fiscal Year 2014.

synergetics usa inc (SURG) Key Developments

Synergetics USA, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended January 31, 2015

Synergetics USA, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended January 31, 2015. For the quarter, the company reported net sales were $18,189,000 against $15,096,000 a year ago. Operating income was $1,198,000 against operating loss of $377,000 a year ago. Income from operations before provision for income taxes was $1,185,000 against loss from operations before benefit for income taxes of $374,000 a year ago. Net income was $952,000 or $0.04 per basic and dilute share against net loss of $225,000 or $0.01 per basic and dilute share a year ago. EBITDA was $1,874,000 against $117,000 a year ago. Adjusted operating income was $2,059,000 against $137,000 a year ago. For second quarter fiscal 2015 ended Jan. 31, adjusted EPS was $0.07 per share, compared to breakeven in the year-ago period. For the six months, the company reported net sales were $34,836,000 against $30,626,000 a year ago. Operating income was $2,355,000 against $1,015,000 a year ago. Income from operations before provision for income taxes was $2,343,000 against $1,021,000 a year ago. Net income was $1,720,000 or $0.07 per basic and dilute share against $709,000 or $0.03 per basic and dilute share a year ago. EBITDA was $3,589,000 against $1,958,000 a year ago. Adjusted operating income was $3,364,000 against $1,529,000 a year ago. Net cash provided by operating activities was $4,783,000 against net cash used in operating activities of $302,000 a year ago. Purchase of property and equipment was $393,000 against $735,000 a year ago. Acquisition of patents and other intangibles was $69,000 against $139,000 a year ago. Non-GAAP EPS was $0.07 compared to $0.00 in the second quarter last year. As of January 31, 2015, the Company had approximately $2.75 million in interest-bearing debt.

Synergetics USA, Inc. to Report Q2, 2015 Results on Mar 10, 2015

Synergetics USA, Inc. announced that they will report Q2, 2015 results at 5:00 PM, US Eastern Standard Time on Mar 10, 2015

Synergetics USA, Inc., Q2 2015 Earnings Call, Mar 10, 2015

Synergetics USA, Inc., Q2 2015 Earnings Call, Mar 10, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SURG:US $5.00 USD +0.02

SURG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ellex Medical Lasers Ltd A$0.36 AUD +0.02
Integra LifeSciences Holdings Corp $61.18 USD +0.43
IRIDEX Corp $10.32 USD -0.04
Misonix Inc $13.11 USD +0.0001
Quantel SA €2.99 EUR -0.01
View Industry Companies
 

Industry Analysis

SURG

Industry Average

Valuation SURG Industry Range
Price/Earnings 32.7x
Price/Sales 1.9x
Price/Book 2.0x
Price/Cash Flow 32.9x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERGETICS USA INC, please visit www.synergeticsusa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.